A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

A special investigation by the Manchester Evening New's Nicole Wootton-Cane has revealed the Ozempic and Wegovy sold on the social media platform despite the risks ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...